News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
BIOTECHNOLOGY VALUE FUND L P
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/10/2023 |
SC 13G
| BIOTECHNOLOGY VALUE FUND L P reports a 8.2% stake in Forte Biosciences, Inc. |
| 07/06/2023 |
SC 13G
| BIOTECHNOLOGY VALUE FUND L P reports a 10% stake in Unicycive Therapeutics, Inc. |
| 06/30/2023 |
SC 13G
| BIOTECHNOLOGY VALUE FUND L P reports a 7.1% stake in Revolution Medicines, Inc. |
| 05/30/2023 |
SC 13G
| BIOTECHNOLOGY VALUE FUND L P reports a 9.8% stake in Janux Therapeutics, Inc. |
| 03/24/2023 |
SC 13G
| BIOTECHNOLOGY VALUE FUND L P reports a 5.1% stake in IDEAYA Biosciences, Inc. |
| 03/20/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 03/16/2023 |
SC 13G
| BIOTECHNOLOGY VALUE FUND L P reports a 5% stake in Aclaris Therapeutics, Inc. |
| 03/06/2023 |
SC 13G
| BIOTECHNOLOGY VALUE FUND L P has filed a Schedule 13D for ASLAN Pharmaceuticals Limited |
| 02/13/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/06/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 01/03/2023 |
SC 13G
| BIOTECHNOLOGY VALUE FUND L P reports a 9.3% stake in Zymeworks Inc. |
| 12/16/2022 |
SC 13G
| BIOTECHNOLOGY VALUE FUND L P reports a 20% stake in NLS Pharmaceutics Ltd. |
| 12/05/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 11/07/2022 |
SC 13G
| BIOTECHNOLOGY VALUE FUND L P reports a 10% stake in Aravive, Inc. |
| 09/29/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 09/26/2022 |
SC 13G
| BIOTECHNOLOGY VALUE FUND L P reports a 9.1% stake in Third Harmonic Bio, Inc. |
| 09/26/2022 |
SC 13G
| BIOTECHNOLOGY VALUE FUND L P reports a 5.4% stake in POINT Biopharma Global Inc. |
| 08/26/2022 |
SC 13G
| BIOTECHNOLOGY VALUE FUND L P reports a 7.5% stake in Vigil Neuroscience, Inc. |
| 07/11/2022 |
SC 13G
| BIOTECHNOLOGY VALUE FUND L P reports a 10% stake in 89bio, Inc. |
| 06/16/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 05/26/2022 |
SC 13G
| BIOTECHNOLOGY VALUE FUND L P reports a 8.7% stake in Annexon, Inc. |
| 05/02/2022 |
SC 13G
| BIOTECHNOLOGY VALUE FUND L P reports a 5.4% stake in iTeos Therapeutics, Inc. |
| 05/02/2022 |
SC 13G
| BIOTECHNOLOGY VALUE FUND L P reports a 5.1% stake in IDEAYA Biosciences, Inc. |
| 04/04/2022 |
SC 13G
| BIOTECHNOLOGY VALUE FUND L P reports a 8.6% stake in AN2 Therapeutics, Inc. |
| 03/24/2022 |
SC 13G
| BIOTECHNOLOGY VALUE FUND L P reports a 5.9% stake in Tyra Biosciences, Inc. |
| 03/14/2022 |
SC 13G
| BIOTECHNOLOGY VALUE FUND L P reports a 5.6% stake in Arcus Biosciences, Inc. |
| 02/14/2022 |
SC 13G
| BIOTECHNOLOGY VALUE FUND L P reports a 6.9% stake in Elevation Oncology, Inc. |
| 02/14/2022 |
SC 13G
| BIOTECHNOLOGY VALUE FUND L P reports a 7.5% stake in Cogent Biosciences, Inc. |
| 02/14/2022 |
SC 13G
| BIOTECHNOLOGY VALUE FUND L P reports a 13% stake in Bionomics Limited |
| 02/14/2022 |
SC 13G
| BIOTECHNOLOGY VALUE FUND L P reports a 17.8% stake in GH Research PLC |
| 01/24/2022 |
SC 13G
| BIOTECHNOLOGY VALUE FUND L P reports a 6.3% stake in Aclaris Therapeutics, Inc. |
| 01/18/2022 |
SC 13G
| BIOTECHNOLOGY VALUE FUND L P reports a 6.8% stake in Sutro Biopharma, Inc. |
| 01/03/2022 |
SC 13G
| BIOTECHNOLOGY VALUE FUND L P reports a 8.9% stake in CytomX Therapeutics, Inc. |
| 12/20/2021 |
SC 13G
| BIOTECHNOLOGY VALUE FUND L P reports a 5.5% stake in Pyxis Oncology, Inc. |
|
|
|